ArticleScientific reports2025
Geographical variations in metal exposure and metabolic disorders in Chile using an exposome approach.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Machine Learning-Enabled Metallomics Reveals Geographic Exposomic Signatures in a Large Brazilian Cohort.Environment & health (Washington, D.C.) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Exposure to metals may disrupt metabolic pathways, contributing to metabolic disorders. Local environmental factors may modulate these effects, emphasizing the importance of territorial disaggregation. This population-based study evaluated geographic variations in exposure to four metals and their associations with obesity, diabetes, metabolic syndrome, and hypertension in Chile. Data from 3,822 participants in the National Health Survey (2016-17) were analyzed. Biomarkers included inorganic arsenic (As), cadmium (Cd), mercury (Hg) in urine, and lead (Pb) in serum. Metal exposure categories were defined according to the median (50th percentile) distribution, contrasting participants above versus below this threshold. Associations between metal exposure and comorbidities were estimated using: (i) survey-weighted models with post-stratification by sex and region, (ii) spatial autoregressive (SAR) models to account for geographical dependencies across regions, and (iii) Bayesian multilevel generalized linear models that incorporated sampling design and regional correlations. 42.4% of individuals were exposed to As, 13.6% to Pb, and 1.7% to Hg and Cd. Elevated As exposure was observed in northern areas, with lead exposure peaking at 29.9%. Adjusted models showed no associations at the national level. However, geographical disaggregation showed that As exposure was linked to obesity across most areas, and to diabetes and metabolic syndrome in the northern and central zones. Hg was associated with all conditions in the central macrozone, whereas Cd exposure was linked to diabetes in the southern. These findings underscore critical regional differences in metal exposure and metabolic disorders, highlighting the need for geographically targeted public health interventions considering an exposome-based approach.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.